The appointment of a new, independent director with a medical and scientific background can signal a shift in strategic focus or an increased emphasis on R&D and clinical applications.
Filing excerpt
On June 16, 2026, the Board of Directors (the “Board”) of Illumina, Inc. (the “Company”) increased the size of the Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., to serve on the Board, effective immediately.
What this signalsFilings often name leadership changes, deals and spending plans.
sec-8kgovernanceChangeGet every 8-K signal for Illumina and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Illumina this week?”
The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/076afeec-6e9f-40ce-88b9-52c6966cc661 returns this record as JSON. POST /v1/companies/enrich returns every signal for illumina.com.
{
"signal_id": "076afeec-6e9f-40ce-88b9-52c6966cc661",
"signal_type": "sec-8k",
"signal_subtype": "governanceChange",
"detected_at": "2026-06-30T07:07:04.993+00:00",
"company": {
"name": "Illumina",
"domain": "illumina.com"
},
"data": {
"detail": "The appointment of a new, independent director with a medical and scientific background can signal a shift in strategic focus or an increased emphasis on R&D and clinical applications. This change in governance often leads to a review of key initiatives and vendor partnerships within the next 3-6 months.",
"metrics": {
"timeframe": "immediate"
},
"summary": "Illumina expands board, appointing Dr. Daniel Skovronsky effective June 16, 2026",
"excerpts": "On June 16, 2026, the Board of Directors (the “Board”) of Illumina, Inc. (the “Company”) increased the size of the Board from nine to ten members and appointed Daniel M. Skovronsky, M.D., Ph.D., to serve on the Board, effective immediately.",
"relevance": 0.9,
"sentiment": "neutral",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/1110803/000111080326000138/ilmn-20260616.htm",
"filing_date": "2026-06-23",
"filing_year": 2026,
"fiscal_year_end": "06/16",
"sales_relevance": "Governance tools needed",
"signal_category": "esg"
}
}
curl https://signals.autobound.ai/v1/signals/076afeec-6e9f-40ce-88b9-52c6966cc661 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"illumina.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.